| Outcome Measures: |
Primary: Area under the serum insulin degludec concentration time curve, Calculated based on insulin degludec concentration in serum, From 0 to last quantifiable observation after single dose of insulin degludec/liraglutide and insulin degludec, assessments from 0 hours to 120 hours|Area under the plasma liraglutide concentration time curve, Calculated based on liraglutide concentration in plasma, from 0 to last quantifiable observation after single dose of insulin degludec/liraglutide and liraglutide, assessments from 0 hours to 72 hours | Secondary: Area under the serum insulin degludec concentration time curve from 0 to infinity after single dose, Calculated based on insulin degludec measured in serum, 0 hours to 120 hours|Maximum observed serum insulin degludec concentration, Calculated based on insulin degludec measured in serum, 0 hours to 120 hours|Time to maximum serum insulin degludec concentration, Calculated based on insulin degludec measured in serum, 0 hours to 120 hours|Terminal elimination half-life for insulin degludec, Calculated based on insulin degludec measured in serum, 0 hours to 120 hours|Area under the plasma liraglutide concentration time curve from 0 to infinity after single dose, Calculated based on liraglutide measured in plasma, 0 hours to 72 hours|Maximum observed plasma liraglutide concentration, Calculated based on liraglutide measured in plasma, 0 hours to 72 hours|Time to maximum plasma liraglutide concentration, Calculated based on liraglutide measured in plasma, 0 hours to 72 hours|Terminal elimination half-life of liraglutide, Calculated based on liraglutide measured in plasma, 0 hours to 72 hours|Number of treatment emergent adverse events, Count, Visit 2 (Day 1, randomisation), Visit 5 (7-14 days after last dosing visit)|Number of treatment emergent hypoglycaemic episodes, Count, Visit 2 (Day 1, randomisation), Visit 5 (7-14 days after last dosing visit)|Local tolerability at the injection site, Count, Visit 2 (Day 1, randomisation), Visit 5 (7-14 days after last dosing visit)
|
